Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended Phase 2 Interventional

A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes

ClinicalTrials.gov ID: NCT02785120

Public ClinicalTrials.gov record NCT02785120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 8:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Study to Evaluate the Efficacy and Safety of TF0023 Spray Versus Placebo in Functional Improvement of Patients With Ischemic Strokes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 2, multicenter, randomized, double-blind (within dose), placebo controlled, parallel-group, dose-range finding study to evaluate the efficacy and safety of TF0023 spray versus placebo in functional improvement of patients with ischemic strokes under standard of care.

Study identification

NCT ID
NCT02785120
Recruitment status
Suspended
Study type
Interventional
Phase
Phase 2
Lead sponsor
Techfields Inc
Industry
Enrollment
225 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 1, 2017 (Actual)
Primary completion
Oct 2024 (Estimated)
Completion
Dec 2024 (Estimated)
Last update posted
Jan 5, 2024

2017 – 2024

United States locations

U.S. sites
24
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Four Peaks Neurology Scottsdale Arizona 85258 —
General Neuronology Scottsdale Arizona 85258 —
Colorado Springs Neurological Associates Colorado Springs Colorado 80907 —
CarePoint, P.C. dba Blue Sky Neurology Englewood Colorado 80113 —
Tenet South Florida / Delray Medical Center Delray Beach Florida 33484 —
The Neurology Research Group Miami Florida 33176 —
Florida Hospital of Orlando Orlando Florida 32803 —
Florida Hospital Orlando Orlando Florida 32803 —
Central Baptist Hospital Lexington Kentucky 40503 —
Henry Ford Health System Detroit Michigan 48202 —
Midwest Physicians Group Kansas City Missouri 64132 —
Washington University School of Medicine - Center for Advanced Medicine (CAM) - Neuroscience Center St Louis Missouri 63110-1032 —
Renown Medical Group Reno Nevada 89502 —
Hackensack Neurology Group Hackensack New Jersey 07601 —
Icahn School of Medicine at Mount Sinai (ISMMS) - Institute for Critical Care Medicine New York New York 10029-6508 —
Neurology and Neuroscience Associates Akron Ohio 44320 —
The Ohio State University Wexner Medical Center (OSUWMC) - Neurovascular Stroke Center Columbus Ohio 43210 —
Providence Stroke Center Portland Oregon 97225-6652 —
Neurovascular Associates of Abington Abington Pennsylvania 19001 —
Coastal Nurology Port Royal South Carolina 29935 —
Chattanooga Neurology Associates - Memorial Office Chattanooga Tennessee 37404-1154 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Neurology Associates of Arlington, PA Mansfield Texas 76063 —
VCU Medical Center Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02785120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 5, 2024 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02785120 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →